Product Description: LLY-283 is a potent, selective and oral protein arginine methyltransferase 5 (PRMT5) inhibitor, with an IC50 of 22 nM and a Kd of 6 nM for PRMT5:MEP50 complex, and shows antitumor activity.
Applications: Cancer-programmed cell death
Formula: C17H18N4O4
References: [1]Zahid Q. Bonday, et al. LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity. ACS Med. Chem. Lett., 2018, 9 (7), pp 612-617.
CAS Number: 2040291-27-6
Molecular Weight: 342.35
Compound Purity: 99.22
Research Area: Cancer
Solubility: DMSO : 100 mg/mL (ultrasonic)/H2O : 3.57 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Histone Methyltransferase